Chlamydia pneumoniae has been suggested as a stimulator of the atherosclerotic process. Mice fed a normal diet were infected intranasally with C. pneumoniae and given one intraperitoneal injection of 14 C-cholesterol tracer per day for 12 days.
INTRODUCTION
The first report of a possible association between Chlamydia pneumoniae infection and atherosclerosis came in 1988 from a small cross-sectional study by Saikku et al. (1988) . After this report, both clinical and experimental studies have been published supporting that C. pneumoniae is involved in the development of atherosclerosis (Leinonen and Saikku 2002; Campbell and Kuo 2004; Watson and Alp 2008) . Different methods of detection have demonstrated its presence in disease-altered tissue from various segments of the arterial system (Grayston 2000; Leinonen and Saikku 2002) . The respiratory pathogen C. pneumoniae is an obligate intracellular bacterium with a unique biphasic lifecycle that may involve a persistent state in which the bacterium is unsusceptible to antibiotics and could cause a chronic infection (Grayston 2000) . Atherosclerosis is considered an inflammatory disease (Ross 1993) and C. pneumoniae has been suggested as an initiator and stimulator of the chronic inflammation in the atherosclerotic plaque (Leinonen and Saikku 2002; Fazio et al. 2009 ). It has been demonstrated that C. pneumoniae infection may stimulate atherogenic responses independently of host immune reactions (Deniset et al. 2010) .
The earliest atherosclerotic lesions are the 'fatty streaks' that consist of aggregations of lipid-rich macrophages (foam cells) and T-lymphocytes in the arterial wall (Ross 1993) . Aggregation of lipids in the vessel wall results in recruitment of inflammatory cells and production of cytokines (Libby 2002) . Attracted monocytes differentiate into macrophages that import the lipids that aggregate in the vessel wall (Hansson, Robertson and Soderberg-Naucler 2006) . In macrophages, the lipid export is inhibited because of the inflammatory reaction, resulting in an increased number of foam cells (Hansson, Robertson and Soderberg-Naucler 2006) . Oxidized low-density lipoprotein (LDL) is highly atherogenic (Steinberg 1997 ) and macrophages infected with C. pneumoniae have been demonstrated to promote oxidization of LDL and formation of foam cells (Kalayoglu and Byrne 1998; Kalayoglu et al. 1999) . Such interactions among bacteria, lipids and immune cells may explain a neverending disease process. Furthermore, atherosclerosis models in mice have shown that C. pneumoniae infection results in larger atherosclerotic lesions (Blessing et al. 2001; Chesebro et al. 2003 ) and more unstable atherosclerotic plaques (Ezzahiri et al. 2003) .
Intracellular cholesterol content is regulated by among others the cholesterol efflux pump ATP binding cassette, subfamily A, member 1 Transporter (Abca1) and the inducible degrader of the LDR receptor (Idol) also known as myosin regulatory light chain interacting protein (Mylip) which are both increased in response to high intracellular levels of cholesterol (Sharpe et al. 2014) . Furthermore, inflammatory mediators, such as proinflammatory cytokines (interferon gamma, tumor necrosis factor alpha) and bacterial lipopolysaccharide, reduce cholesterol efflux by inducing an effect on Abca1 expression (Schmitz GLangmann 2005) . Accordingly, C. pneumoniae infection decreased Abca1 expression in lung carcinoma cells (Korhonen et al. 2013) as well as in macrophage-derived foam cells (Zhao et al. 2014) . In the liver, acute C. pneumoniae infection increased Idol expression, thus lowering the uptake of cholesterol in the liver and increasing cholesterol content in serum (Marangoni et al. 2015) .
During infection, the balance of essential trace elements in both serum and tissues is changed as a response to the host defense reaction (Beisel et al. 2004) . These trace elements are pivotal for proper immune cell function, antioxidative enzymes and development of inflammatory tissue lesions (Ilback and Friman 2007) . In most generalized infections, intestinal zinc (Zn) absorption increases and is then rapidly taken up by the liver, resulting in decreased plasma levels of Zn (Beisel et al. 2004) . Plasma copper (Cu) is generally increased, probably due to the increased synthesis and release of ceruloplasmin, a copperbinding plasma protein produced by the liver and acting as an acute-phase reactant (Beisel et al. 2004) .
Chemokine (C-X-C motif) ligand 2 (Cxcl2) increases during infection, including C. pneumoniae infection, resulting in recruitment of macrophages (Fitch et al. 2010) . Moreover, an increased expression of Cxcl2 has been demonstrated in hyperlipidemic mice (Murphy et al. 2002) . The cytokine interferon gamma (Ifng) is important in the innate and adaptive immune defence against infections and was increased during an acute C. pneumoniae infection in mice (Campbell et al. 2010) .
Our aim was to study the cholesterol metabolism during different phases of an acute C. pneumoniae infection in mice. We examined the effect by C. pneumoniae on cholesterol uptake in the blood, aorta, heart and liver as well as gene expressions of Abca1 and Idol in the liver during 20 days of infection. Furthermore, as biomarkers of infection and inflammatory processes, Cu-and Zn-levels and gene expressions of Cxcl2 and Ifng were measured in the liver.
MATERIALS AND METHODS

Mice
Adult female C57BL/6J mice were purchased from Charles River (Copenhagen, Denmark) and maintained at the Animal Department, Biomedical Centre, Uppsala, Sweden. Mice were housed behind strict hygienic barrier cages (TouchSLIMLine, Tecniplast, Scanbur BK A/S, Denmark) at a temperature of 20 ± 1
• C and a relative humidity of 50 ± 2%. Water and regular chow diet (Labfor R36; Lantmännen, Sweden) were supplied ad libitum.
The animal experiments described in this paper took into account all ethical aspects of the welfare of animals following the recommendations in 'Guide for the Care and Use of Laboratory Animals' of the Swedish National Board for Laboratory Animals (CFN). The study was approved (C146/6) by the local Research Ethics Committee for Experimental Use at the Faculty of Medicine, Uppsala University.
Experimental design
Mice used in the experiment had a mean weight of 18.9±1.1 g on day 0. A clinical isolate of G-954 of C. pneumoniae (from a patient with sinusitis) was propagated in Hep-2 cells and stored in a sucrose-phosphate-glutamate (SPG) solution at -70 • C. On day 0, 17 mice were infected intranasally with 3×10 8 inclusion forming units (ifu) of C. pneumoniae in 30 μl SPG and 17 control mice concomitantly received 30 μl SPG intranasally as previously described (Edvinsson et al. 2008a,b) . All mice, infected and controls, were sedated using Fluothane (Astra Läkemedel, Södertälje, Sweden). From day 1 to day 12 of the infection, all mice received daily intraperitoneal injections of 0.1 μCi 4-14 Ccholesterol (Bio-Nuclear AB, Bromma, Sweden) in 100 μl phosphate buffered saline. This dose, 2.14 nmol cholesterol/day, was used to maintain a stable concentration of 14 C-cholesterol in the blood (Ilback et al. 1990 ). Groups of infected and control mice were then sacrificed on days 4, 8 and 20.
Tissue sampling
Infected and sham-inoculated mice were anaesthetized on days 4 (n = 6/group), 8 (n = 6/group) and 20 (n = 5/group) and then sacrificed. After opening of the thoracic cavity, blood was collected for 14 C-cholesterol analysis using heart puncture with sterile and heparinized syringes. The aorta, heart, lungs and liver were excised, rinsed in sterile 0.9% sodium chloride and aseptically divided. One part of these samples was immediately frozen at -0 • C for subsequent DNA extraction. The remaining part of the aorta, ∼40 mg of the heart and ∼50 mg of the liver, were used for 14 C-cholesterol analyses and collected in pre-weighed sterile glass vials. In addition, liver biopsies, ∼50 mg, were taken and stored at -20
• C for subsequent trace element analyses. Moreover, one part of the lungs was placed in 0.5 ml of SPG for subsequent bacterial isolation in cell culture. For subsequent RNA extraction, samples from the liver were immediately placed in RNAlater (Qiagen, Sollentuna, Sweden) overnight and then stored at -70
DNA extraction of Chlamydia pneumoniae
DNA was extracted from ∼10 mg tissue from the heart, lungs and liver as well as ∼4 mg tissue from the aorta with the QiaAmp DNA mini kit (Qiagen, Sollentuna, Sweden) according to the manufacturer's protocol. Elution was carried out with 50 μl Buffer AE that was reapplied to the column after the first elution step in order to increase the DNA concentration. DNA was then diluted 1:10 in double-distilled water and stored at 4
• C until real-time PCR was performed, i.e. the same day or the day after. In every step of extraction a negative (no-template) control was processed in the same way as the samples.
qPCR for Chlamydia pneumoniae
DNA samples from the aorta, heart, lungs and liver were subjected to qPCR, amplifying a fragment of the C. pneumoniae omp A gene (Kuoppa et al. 2002) as previously described (NystromRosander et al. 2006) . Control samples of a known concentration were included in each run to verify PCR reproducibility by checking for differences in Cq values. The qPCR had previously been validated on tissues involved in the experiment by spiking different tissue samples with a known concentration of bacteria and then checking for differences in Cq values.
Culture of Chlamydia pneumoniae
Lung tissue (∼30-60 mg) was collected in 500 μl SPG and subsequently homogenized in the same solution with a TissueLyser (Qiagen) for 15 s on 30 Hz. Samples were then centrifuged for 10 min at 4
• C at 2500 rpm. The supernatant was diluted in steps of 1:10 in warm cell culture medium (RPMI 1640 supplemented with 10% fetal calf serum, 20 mM HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid), 4 mM glutamine, 20 μg/ml gentamicin and 0.05% NaHCO 3 ) and 1 ml was inoculated in duplicates on confluent Hep-2 cell-layers in 24-well plates. Plates were centrifuged for 1 h at 30
• C at 2270 g and then incubated for 2 h at 35
• C with 5% CO 2 . Cell culture medium was then removed and new cell culture medium supplemented with 1 μg/ml cycloheximide and 40 mM glucose was added. The plates were then incubated for 72 h at 35
• C with 5% CO 2 . Cells were stained with Pathfinder R Chlamydia Culture Confirmation system (Biorad, Hercules, USA) according to instructions from the manufacturer and with 2 μg/ml propidium iodide. The number of inclusions was counted in an inverted microscope with UV illumination. In each set of culture, a negative control (SPG) and a positive control (clinical strain G-954 of C. pneumoniae) were included.
RNA extraction from liver samples
Liver samples stored at -70
• C were thawed and total RNA isolated by applying the NucleoSpin RNA kit with DNAse I (Macherey-Nagel, Düren, Germany) as recommended by the manufacturer. To check the integrity of the RNA, the 28S and 18S ribosomal RNA bands were examined by UV-visualization following agarose gel electrophoresis. Fluorescence-based quantification of the RNA was performed according to the Quant-iT RiboGreen protocol (Molecular Probes, Eugene, USA).
Quantitative gene expression analyses of immune and cholesterol transporter markers
Gene-specific exon spanning primers to murine Cxcl2, Ifng, Abca1 and Idol were designed by the use of University of California Santa Cruz (UCSC) Genome Browser and Primer3 software. The primers were synthetized by Cybergene. The accession numbers and sequences of the primers were as follows: Cxcl2, NM 009140.2, 5 -TCCAGAGCTTGAGTGTGACG-3 (forward) and 5 -CTTTGGTTCTTCCGTTGAGG-3 (reverse); Ifng, NM 008337.3, 5 -GGCCATCAGCAACAACATAA-3 (forward) and 5 -TGAGCTCATTGAATGCTTGG-3 (reverse); Abca1, NM 013454.3, 5 -AGTACCCCAGCCTGGAACTT-3 (forward) and 5 -TGGGT TTCCTTCCATACAGC-3 (reverse); Idol, NM 153789.3, 5 -TTGT GTCAGCGATGGAGAAC-3 (forward) and 5 -CTCCTTGGTG ACGGTCAAGT-3 (reverse). Quantitative gene expression was examined by RT-qPCR using a Rotor-Gene 3000 (Corbett Research, Sydney, Australia) by applying One-Tube QuantiTectSYBR R Green RT-PCR reagents (Qiagen). Expressions of target genes were normalized to the geometric average expression of the three reference genes hypoxanthine-guanine phosphoribosyltransferase 1 (Hrpt1), beta-2 microglobulin (B2m) and 18S ribosomal RNA (18S) as described (Bustin et al. 2009 ). Final primer concentration for target genes was 0.4 μM and 150 ng total RNA was used as template in 25 μl RT-PCR reactions. Reference genes were analyzed as described (Matouskova et al. 2014) . Non-template controls served as blanks and melt curve analysis was performed for each sample to check the specificity of the obtained PCR products. Relative quantification of the normalized mRNA expressions was performed by comparing the quantification cycle (Cq) between the tissues of the Cp-infected animals and the controls according to the 2 −( Cq) -method (Livak and Schmittgen 2001) . Cq 40 was used as cut-off limit for detection of gene expression. Fold differences were calculated setting untreated controls to 1.
Cholesterol determination
The [4-14 C] cholesterol content of blood and tissues was measured with standard liquid scintillation techniques. Before counting, tissue samples were cut into pieces and digested with 1 ml of Biolute S (Zinsser Analytics Ltd, Maidenhead, UK) at 37
• C for 24 h. Samples that contained blood were bleached with 0.5 ml isopropanol and 0.2 ml H 2 O 2 . Finally, 10 ml of scintillation fluid (Quickszint, Zinsser Analytics Ltd, Frankfurt, Germany) were added and then the samples were counted for radioactivity in a liquid scintillation counter (Wallac 1409).
Assessment of trace element levels in the liver
To determine the elements Cu and Zn in liver tissue, the samples were treated as previously described (Edvinsson et al. et al. 2008a,b) . The element content was determined by inductively coupled plasma-mass spectrometry (ICP-MS; PerkinElmer SCIEX ELAN 6000, Perkin Elmer Corp., Concord, Ontario, Canada). For quality control, every eighth sample was checked against a certified reference material: NIST bovine liver 1577a (National Institute of Standards and Technology, Gaithersburg, MD, USA). All reference material measurements for each element were within a maximum deviation of 6% from the stated value while the maximum deviation for precision was 5%. Lung qPCR 6/6 6/6 3/5 Lung culture 5/6 6/6 3/5 Aorta qPCR 3/6 4/6 0/5 Heart qPCR 1/6 0/6 0/5 Liver qPCR 4/6 3/6 1/5
Statistical analysis
All statistical analyses were performed using Statistica 8.0 (StatSoft, Tulsa, OK, USA). One-way analysis of variance was conducted followed by Dunnett's method for multiple comparisons and the Mann-Whitney U-test, all considered significant at P < 0.05.
RESULTS
Clinical response to infection
Mice responded to the infection with expected clinical signs, such as decreased body weight, ruffled fur and inactivity. Signs of disease were most pronounced at days 4-5 of the infection and then gradually resolved.
Chlamydia pneumoniae detection
Chlamydia pneumoniae was detected in the aorta, heart, lungs and liver using qPCR. In addition, bacteria from the lungs were also demonstrated in cell cultures. The number of mice positive for C. pneumoniae in the different organs and with different techniques is shown in Table 1 . Chlamydia pneumoniae was demonstrated with qPCR in the lungs and liver on all sampling days but the number of C. pneumoniae positive mice decreased during the course of the infection. In the heart, C. pneumoniae could only be demonstrated on day 4 of the infection, whereas in the aorta C. pneumoniae was demonstrated on days 4 and 8. Bacteria were demonstrated by culture in the lungs on all sampling days but not in all animals.
Immune markers of inflammation/infection
Gene expressions of the Cxcl2 and the Ifng were measured in the liver on days 4 and 20 and are shown in Fig. 1 . Both markers showed a statistically significant increase on day 4 (Cxcl2 P = 0.012 and Ifng P = 0.020) in infected mice compared to control mice. On day 20, the increase in Cxcl2 had normalized, but Ifng showed a tendency of remaining increase. When comparing only mice where C. pneumoniae was cultured from the lungs with control mice, the differences in gene expressions of these infection markers were even more pronounced on day 4 as are shown in Fig. 2 .
Markers related to cholesterol metabolism
Gene expressions of the inducer for LDL-receptor degradation (Idol) and the apical cholesterol efflux protein (Abca1) were measured in the liver on days 4 and 20 (Fig. 1) . A tendency to increased expression of both genes was noted on day 4 although not statistically significant. On day 20, both Abca1 and Idol gene expressions were normalized. When comparing mice where bacteria were isolated from the lungs by culture with control mice, both gene expressions were significantly increased on day 4 (Abca1 P = 0.037 and Idol P = 0.037) but were then normalized again on day 20 as shown in Fig. 2 .
Cholesterol uptake
The 14 C-cholesterol uptake in infected and control mice in blood, aorta and liver is shown in Fig. 3 . In both groups, blood concentrations of 14 C-cholesterol increased slightly during the first days of administration but thereafter, as intended by the dosing regimen, it reached a steady-state level. In the infected mice, there was a concomitant increase in aortic uptake that was most pronounced at the peak of the disease, i.e. on day 4 of the infection (41%). Noteworthy, there tended to be an increase in aortic uptake also on day 20 (78%), i.e. 6 days after the last administration of 14 C-cholesterol. When comparing 14 C-cholesterol in the aorta only in mice where C. pneumonia was detected by culture in the lungs to control mice, the results on days 4 and 8 did not differ from the other results but on day 20 the tendency to an increase were even more pronounced with a 128% increase. This finding contrasted to the pattern of cholesterol uptake in the liver, i.e. the uptake peaked during the acute phase of the disease, i.e. on days 4 and 8 of the infection, but was normalized after the last administration. In the heart, no evident infectioninduced changes could be demonstrated in 14 C-cholesterol uptake.
Cu and Zn levels in the liver
The concentrations of Cu and Zn in the liver of infected and control mice are shown in Fig. 4 . Notably, both Cu and Zn uptake in the liver peaked on day 4 of the infection, i.e. during the acute phase of the disease. In addition, a tendency of again increasing uptake was noted for both elements on day 20.
DISCUSSION
After the respiratory tract inoculation, C. pneumoniae disseminated to the aorta, heart and liver. Furthermore, the bacteria persisted in the lungs and liver throughout the 20-day study period. A corresponding early immune activation in terms of increased Cxcl2 and Ifng gene expressions was observed in the liver. Blood 14 C-cholesterol levels seemed to increase earlier in C. pneumoniae-infected mice but after day 4 the levels were not affected by the infection. However, 14 C-cholesterol accumulation increased in the aorta on day 4 of the infection and tended to increase again on day 20. Cholesterol content in the liver increased on days 4 and 8, but normalized on day 20. In mice, where C. pneumonia was cultured from the lungs (indicating active bacteria), both Abca1 and Idol were increased on day 4. These results indicate that C. pneumoniae has the potential to initiate an atherosclerotic process even in mice fed a normal diet. The highest amount of C. pneumoniae, as expected because of the intranasal route of inoculation, was found in the lungs. Furthermore, as we (Edvinsson et al. 2008a,b) and others (de Kruif et al. 2005 ) have demonstrated, this respiratory bacteria disseminated to the heart, aorta and liver. Notably, C. pneumoniae was found in the liver throughout the study period, i.e. even at 20 days after the inoculation and when the mice showed no clinical signs of infection or responses in the liver of the immune marker Cxcl2. However, gene expression of Ifng in the liver tended to remain increased in the infected animals on day 20. As increased Ifng levels induce chronic and persistent C. pneumoniae infection in cell cultures (Mehta et al. 1998) , this may further support the development of a chronic infection. Moreover, C. pneumoniae was demonstrated in the lungs by culture throughout the study period, i.e. until day 20, further supporting this bacterium to be able to cause long-term and latent infections.
The balance of several trace elements in both serum and tissues is known to change during infection (Beisel et al. 2004; Ilback and Friman 2007) , including C. pneumoniae infection (Edvinsson et al. 2008a,b) . This redistribution of trace elements may partly be immune mediated and partly to deprive pathogens of these elements (Al-Younes et al. 2001; Beisel et al. 2004) . In this study, both Cu and Zn were increased on day 4 of the infection in the liver, similarly to increases in gene expressions of Cxcl2 and Ifng, but were then normalized. Correspondingly, clinical signs were also most severe around day 5. Consequently, C. pneumoniae colonization in the liver seems to induce immune-mediated reactions and concomitant trace element uptake. Furthermore, there was a tendency of Cu and Zn levels to increase again on day 20 in the liver, as well as a tendency of increased Ifng expression, but no clinical signs of disease were observed. This highlights the need for future studies extended in time. Chlamydia pneumoniae infection has been demonstrated to accelerate the atherosclerotic process in hyperlipidemic mice (Campbell and Kuo 2004; de Kruif et al. 2005) . It seems that this infection in mice can generate proatherogenic changes in the vascular wall affecting the macrophage cholesterol homeostasis and endothelial function (Tuomainen et al. 2011) . Moreover, macrophages infected with C. pneumoniae promoted oxidization of LDL and formation of foam cells, which are early atherosclerotic signs (Kalayoglu and Byrne 1998; Kalayoglu et al. 1999) . In mouse models, hyperlipidemia is required for atherosclerosis to develop, either through the diet or through the use of genetically modified mice (de Kruif et al. 2005) . In addition, repeated C. pneumoniae inoculations led to increased lipid areas in the aorta of mice fed a high cholesterol diet (Blessing et al. 2001) . When fed a normal diet, mice infected with C. pneumoniae developed inflammatory lesions in the aorta, but not clearly visible atherosclerotic changes (Blessing et al. 2000) . However, a recent report demonstrated that even in mice fed a normal chow diet, C. pneumoniae infection induced dyslipidemic effects with increased serum cholesterol and reduced liver bile acids during the acute phase of the infection (Marangoni et al. 2015) . In this study, blood cholesterol was increased in the early phase of the infection as well as the uptake of cholesterol in the aorta. Even though the increased uptake was small, it may have a serious impact in the long run, corresponding to the clinically slow rate of normal atherosclerosis development.
In vitro studies have demonstrated a decrease in Abca1 expression in lung carcinoma cells (Korhonen et al. 2013) , macrophages (Liu et al. 2010 ) and foam cells (Zhao et al. 2014) when infected with C. pneumoniae. This decrease in Abca1 expression reduces the export of cholesterol from the cells and may have an impact on the atherosclerotic process. Interestingly, only viable C. pneumoniae were able to downregulate expression of Abca1 in foam cells (Zhao et al. 2014) . In this study, both Abca1 and Idol expressions were increased in the liver during the acute phase of the infection concomitant with an increase of cholesterol in the liver. Notably, the increase of Abca1 and Idol expressions were only significant in mice where C. pneumoniae were cultured from the lungs, indicating ongoing infection with active bacteria. An interesting study by Marangoni et al. (2015) also demonstrated increased Idol expression in the liver together with increased serum lipid levels only in mice with viable C. pneumoniae in the liver. These results further support C. pneumoniae to be involved in the development of atherosclerosis.
During the course of the disease, there was an early increase in the total level of cholesterol in the blood that later was normalized. Accordingly, increased Idol and Abca1 was observed in the liver on day 4 in mice with where the bacterium was cultured from the lungs. This observation, together with no indication of increased cholesterol uptake in the heart, suggests an active accumulation of lipids in the infected aorta, probably induced by the bacteria and/or immune-mediated mechanisms as reflected by the changes in Cu and Zn, and in Cxcl2 and Ifng. As far as we know, in vivo studies of tissue lesions caused by the infection have not been able to distinguish between the host immune-mediated responses in the infected tissue and those direct effects caused by bacterial replication. Nevertheless, cell culture experiments have demonstrated that intracellular growth of Chlamydia species requires host cell lipids, such as cholesterol (Carabeo, Mead and Hackstadt 2003) . Although visible atherosclerotic lesions have been observed to develop only in infected mice on a high-fat diet, our results suggest that a high-fat diet may not be required for initiating the disease process. Therefore, C. pneumoniae may be involved in the atherosclerotic process by exerting an effect on the cholesterol metabolism that together with other factors such as e.g. other infections (Espinola-Klein et al. 2002) and smoking, hyperlipidemia and hypertension (Achneck et al. 2005) results in the development of atherosclerosis.
In conclusion, when all results are taken together including an increased cholesterol uptake in the aorta during C. pneumoniae infection in mice fed a normal diet, it further supports the position that C. pneumoniae may be involved in the development of atherosclerosis, possibly as an initiating factor leading to a disturbed cholesterol metabolism. Thus, C. pneumoniae and other infectious agents may have to be seriously considered as co-factors, or even primary pathogenic factors, in the development of atherosclerosis.
